Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiovascular Function in Leukemia Patients: an Observational Prospective Study

NCT03760237 is registered in ClinicalTrials.gov with Abramson Cancer Center at Penn Medicine as lead sponsor.

NCT NCT03760237
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03760237 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiovascular Function in Leukemia Patients: an Observational Prospective Study
Lead sponsor
Abramson Cancer Center at Penn Medicine
Phase
Observational
Overall status
Completed
Start date
December 10, 2018
Completion date
May 6, 2024
Enrollment
84 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiotoxicity, leukemia, lymphoid, acute, leukemia, myeloid, acute